New - European Medical Journal

Continue

News

Oncology
19 Dec 2016

Depression in Cancer Patients Leads to Worse Treatment Outcomes

DEPRESSION can lead to a poorer prognosis in cancer patients as a result of the decreased amounts of brain-derived neurotrophic factor (BDNF) in their…
Oncology
19 Dec 2016

RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. In South Korea

Israel, December 14, 2016 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily…
General Healthcare
19 Dec 2016

Bluebird Bio and Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement

USA and Germany, December 15, 2016 – bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene…
Oncology
19 Dec 2016

First Data on Rare Sarcomas in Asian Patients Presented at ESMO Asia in Singapore

Lugano-Singapore, December 17, 2016 – The first data on rare sarcomas in Asian patients is presented in three studies today at the ESMO Asia 2016…
Oncology
19 Dec 2016

New Autoimmune Mutation Found in Enteritis Pathogenesis

NOVEL immunotherapy has successfully ameliorated the symptoms of autoimmune enteritis following the discovery of a genetic mutation within an immune…
Innovations
19 Dec 2016

Discovery Could Lead to New Treatments for Parkinson’s Disease

A BIOLOGICAL link has been discovered between the gut microbiome and Parkinson’s disease (PD), potentially leading to the development of new…
EMJ
General Healthcare
16 Dec 2016

EMJ Weekly News Round-Up: 12th December

Keeping you up to date with the latest news, summarising a selection of stories from us here at EMJ and from across the web.
Oncology
16 Dec 2016

Prognostic Models Predict Survival in Cancer Patients Receiving Palliative Care

THE FINDINGS of a new study have identified a group of prognostic models with a good ability to predict survival in cancer patients receiving…
We’ve noticed you’re accessing
from North/South America.